GLOFIL-125 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Glofil-125, and when can generic versions of Glofil-125 launch?
Glofil-125 is a drug marketed by Isotex and is included in one NDA.
The generic ingredient in GLOFIL-125 is iothalamate sodium i-125. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the iothalamate sodium i-125 profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for GLOFIL-125?
- What are the global sales for GLOFIL-125?
- What is Average Wholesale Price for GLOFIL-125?
Summary for GLOFIL-125
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 6 |
Clinical Trials: | 1 |
Patent Applications: | 4 |
What excipients (inactive ingredients) are in GLOFIL-125? | GLOFIL-125 excipients list |
DailyMed Link: | GLOFIL-125 at DailyMed |
Recent Clinical Trials for GLOFIL-125
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Colorado, Denver | Phase 4 |
Pharmacology for GLOFIL-125
Drug Class | Radioactive Diagnostic Agent |
Mechanism of Action | Radiopharmaceutical Activity |
US Patents and Regulatory Information for GLOFIL-125
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Isotex | GLOFIL-125 | iothalamate sodium i-125 | INJECTABLE;INJECTION | 017279-001 | Approved Prior to Jan 1, 1982 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |